Emergent BioSolutions Inc. signs contract for third generation anthrax vaccine candidate
by Pat Dulnier on September 1, 2010


Hdsht_daniel_abdun_nabi

Daniel J. Abdun-Nabi

Emergent BioSolutions Inc. has signed a contract for advanced development of its third generation anthrax vaccine candidate.

DTRA announces contract with Stabilitech
by Pat Dulnier on August 27, 2010


Stabilitech_75x50

Stabilitech has announced a $4 million contract with the United States Defense Threat Reduction Agency to provide vaccine stabilization procedures.

Iowa man indicted for anthrax hoax letters
by Pat Dulnier on August 26, 2010


Envelope

A Winterset, Iowa, man was recently indicted for sending threatening letters containing a white, powdery substance.

Emergent BioSolutions, Inc. hosts biomedical symposium
by Pat Dulnier on August 25, 2010


C471970

Fuad El-Hibri

Emergent BioSolutions, Inc., recently hosted a symposium with the NIH-Oxford-Cambridge Scholars Program at the company’s product development facility in Gaithersburg, Maryland.

Abandoned chemicals from biological weapons defense facility detonated
by Pat Dulnier on August 12, 2010


Biohazard8

Officials with the San Diego Fire Rescue team were on scene to detonate abandoned hazardous material last week at a facility in Sorrento Valley, Calif.

CEO of Capitol Visitor Center fired
by Pat Dulnier on July 28, 2010


Images

Terrie Rouse

The CEO of the multi-million dollar Capitol Visitor Center has been fired just one month after a supervisor at the visitor center flushed a bag labeled "Anthrax" that contained white powder down a public toilet before notifying U.S. Capitol Police.

Canada calls for proposals to fight bioterror
by Pat Dulnier on July 22, 2010


Icons

Canada's federal government has called for proposals to combat biological, chemical, radiological and nuclear attacks, offering $18 million for ideas.

Anthrax outbreak in United Kingdom slowing
by Pat Dulnier on July 13, 2010


Anthrax2

Anthrax

There has only been one new reported case of anthrax related to heroin use in the United Kingdom since May, leading many to believe that the outbreak among users has come to an end.

Appeal of South African chemical and biowarfare project head denied
by Pat Dulnier on June 30, 2010


Basson

Wouter Basson

An appeal by the former head of a secret South African chemical and biological warfare project to overturn a court ruling that allowed his conduct to be probe was recently dismissed in Pretoria, South Africa.

Two teens charged in S.C. anthrax hoax
by Pat Dulnier on May 6, 2010


Picture_2

St. James High School

Two South Carolina teens were charged with disturbing schools after a “joke” sparked a serious hazmat scare at their Murrells Inlet high school on April 29, police have announced.

ATF purchases biodetection equipment
by Pat Dulnier on May 5, 2010


Picture_1

Anthrax detection kit

The Bureau of Alcohol, Tobacco, Firearms and Explosives has entered a purchase order for Universal Detection Technology's 5-agent detection kits and training equipment that will be used to instruct agents in the proper use of the kits.

Alabama men indicted for multiple anthrax threats
by Pat Dulnier on April 30, 2010


Large_richard_shelby

U.S. Sen. Richard Shelby

Two Alabama men were indicted on Wednesday by a federal grand jury in connection with a series of anthrax hoax letters mailed in Alabama this month and in March.

Calif. man indicted for anthrax threat
by Pat Dulnier on April 21, 2010


Screen_shot_2010-04-20_at_4

Anthrax

A Livermore, Calif., man who was convicted in 1999 of threatening to release anthrax in an Oakland federal building, has been indicted by a federal grand jury on charges of making another threat, according to court records.

Blue Pharmaceuticals LLC to produce anthrax vaccine in Puerto Rico
by Pat Dulnier on April 15, 2010


Anthrax2

Anthrax

The Franklin, Kentucky-based Blue Pharmaceuticals LLC has opened a new manufacturing facility in Dorado, Puerto Rico, this week that will manufacture ciprofloxacin, its anthrax antidote, among other pharmaceuticals.

Anthrax threat against Rep. Weiner traced to Brooklyn
by Pat Dulnier on April 6, 2010


Anthrax2

Anthrax

Authorities have potentially traced the mailing location of the March 25 anthrax letter hoax that caused the Queens office of Rep. Anthony Weiner to temporarily shut down to Brooklyn.

Tularemia detected in Ohio air
by Pat Dulnier on April 5, 2010


Tularemia

Tularemia

Air sampling performed by health officials in Columbus, Ohio, has revealed the presence of the potentially dangerous Tularemia bacteria this week according to 10TV News.

Whistleblower warns of biothreats at census center
by Pat Dulnier on April 2, 2010


Anthrax-bacteria

Anthrax

The National Processing Center in Jeffersonville, Kentucky, is charged with processing the millions of census forms that are arriving at its doors.

National Biodefense Science Board makes CBRN recommendations
by Pat Dulnier on March 29, 2010


Icons

The National Biodefense Science Board has recommended that a major effort be launched by the federal government to better focus its activities on developing medical countermeasures for biological, chemical, radiological and nuclear threats.

Panel of experts discusses past, future of bioterror
by Pat Dulnier on March 25, 2010


Anthrax2

Anthrax

A March 19 briefing titled "Deterring Biological Threats," hosted by the Center for a New American Security, brought together a panel of experts to discuss the threat of biological weapons.

India and U.S. discuss joint CBRN exercise
by Pat Dulnier on March 24, 2010


India-flag

A joint training exercise in biological, chemical and nuclear warfare between the United States and India is currently under consideration following a U.S. proposal, the Indian newspaper The Tribune has reported.

HGS and BioInvent announce collaboration
by Pat Dulnier on March 12, 2010


Human-genome-sciences-logo

Human Genome Sciences, Inc., and BioInvent International AB have announced a collaboration meant to discover, develop and commercialize therapeutic monoclonal antibodies that have would specifically target antigens discovered by HGS.

Biothreats to agriculture highlighted
by Pat Dulnier on March 1, 2010


Icons

The International Agri-Center in Tulare, California was recently visited by government officials in an attempt to raise awareness of the threat, impact and response needs in the face of potential terrorist attacks on the agricultural sector.

Further review sought of 2001 anthrax mailings
by Pat Dulnier on February 26, 2010


Anthrax-bacteria

Anthrax

Further review is being sought by the United States House of Representatives over the 2001 anthrax mailings that resulted in five deaths that was recently closed by the FBI.

HHS Sec. Sebelius speaks on health preparedness
by Pat Dulnier on February 19, 2010


Sebelius_kathleen

Kathleen Sebelius

U.S. Health and Human Services Secretary Kathleen Sebelius spoke about efforts to strengthen health preparedness at this week's 2010 Public Health preparedness Summit.

Smiths Detection to distribute BioCheck powder screening test kits
by Pat Dulnier on February 18, 2010


Biocheck_kit

BioCheck Powder Screening Test Kit

A worldwide distribution agreement has been announced by Smiths Detection with 20/20 BioResponse for its patented BioCheck powder screening test kits

Calif. water utility secures unmanned stations from biothreats
by Pat Dulnier on February 11, 2010


Alco-water

ALCO Water Service

The investor-owned Alco Water Service has begun using an RFID-based system for security at its unmanned pump stations throughout Salinas, Calif., bringing them into compliance with the Bioterrorism Act of 2002.

Denmark institutes new rules for handling certain biological substances
by Pat Dulnier on February 5, 2010


Icons

Beginning May 1, hospitals, researchers and companies in Denmark will be required to apply for a license to use certain substances that could be used to make biological weapons.

New study shed light on how citizens will react to bio-outbreak
by Pat Dulnier on February 4, 2010


Wash-hands

A new study has highlighted how people behave during pandemics and potentially paved the way to predict protective behaviors by identifying key demographic and psychological factors, giving light on how populations might react to a bioterror event.

England reveals increased monitoring for dirty bombs, bioweapons
by Pat Dulnier on January 19, 2010


Bioweapons

Major British ports have had high-tech machines installed to detect any materials that could potentially be used to build "dirty bombs," it has been revealed.

Source of 1981 anthrax attack in Scotland revealed
by Pat Dulnier on January 15, 2010


Anthrax2

Anthrax

Newly uncovered secret files have revealed that the culprits of a 1981 anthrax attack in Scotland were a shadowy group known as the Scottish Civilian Army.

Aethlon Medical advances therapeutic device for biological warfare pathogens
by Pat Dulnier on January 14, 2010


Redchip

A company developing a therapeutic device meant to treat acute and chronic viral infections, biological warfare pathogens and other conditions has issued a research update.

Anthrax scare in Britain's House of Commons
by Pat Dulnier on December 31, 2009


Anthrax2

An envelope sent to Britain's Communities minister Shahid Malik was found to be filled with a white power and triggered an anthrax scare at the House of Commons.

Third anthrax death in Glasgow
by Pat Dulnier on December 30, 2009


Anthrax-bacteria

Anthrax

Doctors have confirmed that a heroin user who died last week was infected with anthrax, bringing the total deaths from infections to three.

Third anthrax infection identified in Glasgow
by Pat Dulnier on December 23, 2009


Anthrax-bacteria

Anthrax

A heroin user has been identified as the third case of anthrax infection in Glasgow, Scotland by health officials.

New tools will fight bioterrorism in food supply chain
by Pat Dulnier on December 23, 2009


Fda-logo

A new set of tools designed by the FDA and the United States Department of Agriculture aims to aid food-animal producers in mitigating risk of bioterrorism on the food production process.

- British Royal Society calls for more realistic bio-attack exercises
by Pat Dulnier on December 16, 2009


Brit-royal-soc

Britain's Royal Society

Britain's Royal Society has warned that more realistic exercises need to be conducted to improve emergency responses to both chemical and biological attacks.

Sen. Mark Pryor announces plans for bill that would make attacks eligible for federal emergency assistance
by Pat Dulnier on December 14, 2009


Pryor-mark

Sen. Mark Pryor

U.S. Sen. Mark Pryor has announced plans to file a bill that would make terrorist attacks, public health emergencies and man-made disasters eligible for federal emergency assistance.

Singapore debuts bioterror attack tracing software
by Pat Dulnier on December 11, 2009


Bioweapons

DSO National Laboratories, Singapore's defense research and development organization, has created software to monitor the spread of chemical agents in real-time.

Brookline, Mass., stages bioterror drill
by Pat Dulnier on December 3, 2009


Vaccine

Emergency Vaccinations

More than 100 volunteers will take part in a rapid vaccination program in Brookline, Mass., this weekend to prepare the town for a serious pandemic situation or a bioterrorist attack.

UAE officials given bioterrorism training
by Pat Dulnier on November 30, 2009


Uae-flag

United Arab Emirates

The United Arab Emirates is not currently facing a bioterrorism threat but it is not taking any chances.

Tiny silicon chip to increase first responders' ability to diagnose bio attack
by Pat Dulnier on November 24, 2009


Silicone_chip

Microfluidic Chip

A tiny chip based on silicon produced by IBM's research labs in Zurich could soon be used by first responders to quickly diagnose dozens of diseases faster and with less blood required than normal.

Gene synthesis firms unite to tighten security
by Pat Dulnier on November 23, 2009


Dna

DNA

The five companies - DNA 2.0, GeneArt, GenScript, Integrated DNA Technologies and Blue Heron Biotechnology - provide 80 percent of global gene synthesis capacity.

Maryland biopharmaceutical company purchases East Baltimore bioscience center
by Pat Dulnier on November 17, 2009


Emergent

A Rockville, Maryland based biopharmaceutical company has purchased the East Baltimore bioscience nonprofit MdBio Foundation's 55,000-square-foot BioProcessing Center in East Baltimore.

Emergent BioSolutions acquires manufacturing facility from MdBio
by Pat Dulnier on November 13, 2009


El-hibri_fuad

Fuad El-Hibri

ROCKVILLE, Md. — Emergent BioSolutions Inc. has completed the acquisition of a 55,000-square-foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the city of Baltimore.

Kent State University becomes 2nd in U.S. to offer biosafety training
by Pat Dulnier on November 12, 2009


Woolverton_f

Chris Woolverton

KENT, Ohio — The increasing number of high-containment laboratories and the constant threat from emerging diseases and bioterrorism require more extensive biosafety training of the highest caliber.

Scientists Announce Possible Treatment for Deadly Virus
by Pat Dulnier on November 11, 2009


Hendra_csiro

Hendra Virus

A team of Australian and U.S. scientists believe they have found an antibody that could protect humans from the deadly Hendra virus, Australia's Northern Miner reported yesterday.

Ricin antidote to enter production
by Pat Dulnier on November 11, 2009


Castorbeans

Ricin source

An anti-toxin that protects against ricin poisoning is to move into production for the first time, BBC News reported Nov. 11.

Cox elected chairman of IAEM
by Pat Dulnier on November 7, 2009


Cox-rick

Rick Cox

Rick Cox, senior planner of IEM Inc., has been elected global board chairman of the International Association of Emergency Managers.

Committee sends Weapons of Mass Destruction bill to Senate
by Pat Dulnier on November 6, 2009


Collins_susan

Susan Collins

WASHINGTON, D.C.-- The Senate Homeland Security and Governmental Affairs Committee on Nov. 4 recommended the Weapons of Mass Destruction Prevention and Preparedness Act for a vote by the full Senate.

Uganda officials fear plague outbreak as rainy season begins
by Pat Dulnier on October 29, 2009


Plaguecarryingflea

Plague-carrying flea

KAMPALA, Uganda — Health officials have launched a plague prevention campaign in the Nebbi district, which was most recently hit by the vector-borne disease a year ago.

JPL develops high-speed test to improve pathogen decontamination
by Pat Dulnier on October 27, 2009


Adrian_ponce

A chemist at NASA's Jet Propulsion Laboratory in Pasadena, Calif., has developed a technology intended to rapidly assess any presence of microbial life on spacecraft.

Army breaks ground for bigger biodefense lab at Fort Detrick
by Pat Dulnier on October 19, 2009


Schoomaker_med

Lt. Gen. Eric B. Schoomaker

FREDERICK, Md. — The U.S. military's flagship biological defense agency has broken ground on a $680 million headquarters building designed for expanded Army research on the world's deadliest pathogens.

Napolitano announces $88 million for port inspection technology
by Pat Dulnier on October 18, 2009


Port_security_image_1

Department of Homeland Security Secretary Janet Napolitano announced $88 million in funding for non-intrusive Inspection equipment to scan commercial traffic for contraband through X-ray and other imaging technologies.

States, municipalities could get biological agent detection kits
by Pat Dulnier on October 17, 2009


S_cbrn2

Universal Detection Technology, a developer of early warning monitoring technologies and counter-terrorism training programs, announced Oct. 19 that it is preparing for inclusion in a disaster preparedness contract established in New York after Sept. 11,

Emergent BioSolutions submits its plan for vaccine contract to FDA
by Pat Dulnier on May 13, 2009


Abdun_nabi

Daniel J. Abdun-Nabi,

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced May 13, 2009, that it has submitted to the U.S. Food and Drug Administration a development plan for the company’s recombinant protective antigen anthrax vaccine candidate.

Emergent BioSolutions acquires advanced anthrax vaccine candidate, technology
by Pat Dulnier on May 5, 2008


El-hibri_fuad

Fuad El-Hibri

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced that it has completed the acquisition of all assets and rights related to a recombinant protective antigen (rPA) anthrax vaccine product candidate and related technology from VaxGen Inc.


Browse by Location

Search

Subscribe to our newsletter

Enter your Email


Preview | Powered by FeedBlitz

RSS Feed

RSS Feed